Juniper Genomics
6 known investors
Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample. Its products serve fertility clinicians and IVF patients making embryo selection and genetic risk decisions.
Investors · 6
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundJul 2025 · 2 sources
Company Ventures (lead), Amboy Street Ventures, Blue Collective, Dria Ventures, Innospark Ventures, MBX Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Juniper Genomics went on to found or lead other companies.
Competitors · 8
by search overlap
Orchid Health13 shared keywordsOrchid offers whole genome sequencing-based genetic screening of embryos during IVF as well as preconception testing for couples, analyzing DNA to identify predispositions to monogenic diseases, chromosomal abnormalities, and polygenic risks. It serves prospective parents and IVF patients, delivering reports reviewed by board-certified genetic counselors.
Genomic Prediction12 shared keywordsLifeView provides preimplantation genetic testing for IVF embryos, including screening for chromosomal abnormalities (PGT-A/A+), single-gene disorders (PGT-M), structural rearrangements (PGT-SR), and its Embryo Health Score polygenic risk test. Its services target prospective parents and fertility clinics seeking to improve IVF success rates and reduce miscarriage and genetic disease risk.
Labcorp12 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Invitae8 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Nucleus Genomics8 shared keywordsNucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.
Myriad7 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
NeoGenomics6 shared keywordsNeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
Progyny6 shared keywordsProgyny provides employer-sponsored women's health and family-building benefits, covering preconception, fertility, pregnancy and postpartum, and menopause/midlife care through concierge support, digital tools, and a managed network of specialists. It serves organizations looking to offer these benefits to their workforce across the United States.
Companies competing with Juniper Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Juniper Genomics do?
- Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample. Its products serve fertility clinicians and IVF patients making embryo selection and genetic risk decisions.
- Who are Juniper Genomics's investors?
- Juniper Genomics's investors include Amboy Street Ventures, Dria Ventures, Blue Collective, Company Ventures, Innospark Ventures, MBX Capital.